NEUVOGEN Appoints Biotechnology Veteran, Mark Backer, PhD as Head of Technical Operations - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ NEUVOGEN, an immunoncology company, announced today that Mark Backer, PhD has joined the company as Head of Technical Operations, and will be.
/PRNewswire/ NEUVOGEN, an immunoncology company, is pleased to announce the appointment of George Montgomery as Chief Financial Officer. He will oversee.
/PRNewswire/ NEUVOGEN, an immunoncology company, is pleased to announce the appointment of George Montgomery as Chief Financial Officer. He will oversee.